Skip to main content
. 2016 Jan 25;2:15069. doi: 10.1038/cddiscovery.2015.69

Figure 6.

Figure 6

Novel protein interactions reveal regulators of endocytosis and filopodia formation in blebbishields. (a) GST pulldown using RalGDS-RBD as bait showed constitutive interactions of cdc42, PKC-ζ, K-Ras, full-length and cleaved β-catenin, and internal VEGFR2 with E-cadherin in RT4P cells; interactions with E-cadherin and full-length β-catenin were lost in blebbishields. Note: the blebbishield lane and blebbishield (BS)-depleted cells lane are fractions of the blebbishield ejection (BE) medium lane. (b) Proposed model of E-cadherin-mediated locked state and how caspase-3 cleavage of β-catenin could release RalGDS and interaction partners from E-cadherin-mediated lock. Cl., cleaved. (c) Selective interaction of p45S6K (caspase-3-cleaved p70S6K) and PKM-ζ (cleaved PKC-ζ) with PAK-1-CRIB domain along with filopodia initiator cdc42. Cl., cleaved; iso, isoform. (d) Caspase-3-mediated cleavage of p70S6K and PKC-ζ to generate p45S6K and PKM-ζ to generate serpentine filopodia. (e) Mapping caspase-3 cleavage site PVD in p70S6K and PKC-ζ to generate constitutively active form devoid of auto-inhibitory domain (AID) but with intact kinase domain (KD/PKD). The epitopes for the corresponding antibodies are also shown to explain why these antibodies are capable of detecting p45S6K and PKM-ζ. (f) Western blotting showing that blebbishields retain phosphorylation of ribosomal S6 protein, a target of p70S6K (left). Isolated RT4P blebbishields form spheres (indicating transformation), and inhibition of S6K with BI-D1870 abolishes transformation from blebbishields (right). Cl., cleaved; Ph., phosphorylated; Tot., total.